Bioretec
2.08
EUR
-4.59 %
1,525 following
BRETEC
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Investor consensus
-4.59%
-12.24%
-11.86%
-13.33%
-5.88%
-24.64%
+0.48%
-
-29.26%
Bioretec is a medical technology company. The company specializes in the development of medical devices. The product portfolio includes, for example, implants for pediatric and adult orthopedics and other material for bone and soft tissue injuries. In addition to the main business, service and associated ancillary services are also offered. Bioretec operates worldwide with the largest presence in the Nordic region.
Read moreMarket cap
51.1M EUR
Turnover
75.8K EUR
P/E (adj.) (25e)
-10.39
EV/EBIT (adj.) (25e)
-11.86
P/B (25e)
9.59
EV/S (25e)
7.04
Dividend yield-% (25e)
-
Coverage

Analyst
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
15/5
2025
Business review Q1'25
14/8
2025
Interim report Q2'25
13/11
2025
Business review Q3'25
Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
Bioretec Ltd - Managers' transactions - Michael Piccirillo
Bioretec Ltd - Managers' transactions - Kustaa Poutiainen
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools